Blood Cancer Treatment Landscape
Ginna Laport, VP and Global Head of Lymphoma at Genentech discusses types of blood cancers, the historic treatment challenges, and new research and treatment options that are changing the way people fight cancer. Recent studies show new innovative treatments that fight cancer without chemotherapy are effective and safe and could help a wide range of patients in need. She also talks about the impact COVID-19 has had on patient regimens.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Ginna Laport, VP and Global Head of Lymphoma at Genentech discusses types of blood cancers, the historic treatment challenges, and new research and treatment options that are ch…
- Key Point: Recent studies show new innovative treatments that fight cancer without chemotherapy are effective and safe and could help a wide range of patients in need.
- Key Point: She also talks about the impact COVID-19 has had on patient regimens. Ginna is the current VP and Global Head of Lymphoma as part of the chronic lymphocytic leukemia franchise.
- Key Point: Prior to Genentech, she was a CMO at Tempest Therapeutics and part of the clinical development team at Corvus Pharmaceuticals.
- Key Point: During Ginna’s tenure in academia, she was faculty in the Stanford University School of Medicine, most recently as a professor in the Division of Blood and Marrow Transplantat…
Ginna is the current VP and Global Head of Lymphoma as part of the chronic lymphocytic leukemia franchise. Prior to Genentech, she was a CMO at Tempest Therapeutics and part of the clinical development team at Corvus Pharmaceuticals. During Ginna’s tenure in academia, she was faculty in the Stanford University School of Medicine, most recently as a professor in the Division of Blood and Marrow Transplantation (BMT). Her research focused on adoptive immunotherapies for malignant diseases and she served as director of clinical research in the BMT Division and as an associate director of the Stanford Cancer Institute.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



